law.justia.com/cases/federal/appellate-courts/cadc/16-5356/16-5356-2018-06-19.html

Jun 19, 2018 ... Therefore, all of the communications were protected by the ... FTC v. Boehringer Ingelheim Pharmaceuticals, Inc., No. 16-5356 (D.C. Cir. 2018).

www.cadc.uscourts.gov/internet/opinions.nsf/A81BAEEA3D756416852582B100518ADF/$file/16-5356.pdf

Jun 19, 2018 ... Boehringer Ingelheim Pharmaceuticals, Inc. Warren D. ... alleged infringer, rather than the other way around.” FTC v. Actavis, Inc., 570 U.S. 136, 141 (2013). .... All of those communications are protected by the attorney-client ...

www.law360.com/cases/59820bc59c43e06ea0000001

Parties, docket activity and news coverage of federal case AbbVie Inc. et al v. Boehringer Ingelheim International GMBH et al, case number 1:17-cv-01065, from Delaware Court. ... Pharma Cases To Watch In 2018's Home Stretch. Drugmakers ...

www.lexislegalnews.com/articles/27314/judge-absence-of-pradaxa-antidote-isn-t-a-design-defect

Jun 6, 2018 ... Boehringer Ingelheim Pharmaceuticals, Inc., et al., No. ... lack of an antidote for the anticoagulant is a design defect (Claude R. Knight, et al. v.

caselaw.findlaw.com/us-7th-circuit/1545486.html

NAIK v. BOEHRINGER INGELHEIM PHARMACEUTICALS INCORPORATED ... was fired by his employer, Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), ... 621 et seq., and Title VII of the Civil Rights Act of 1964, 42 U.S.C. §§ 2000e et seq. ... At a sales meeting in early 2005, Somers informed all district managers that ...

lexmachina.com/researching-attorneys-in-pacer-a-comparison-with-lex-machina

Feb 9, 2016 ... For example, in Boehringer Ingelheim Pharma Gmbh et al v. Kremers Urban Pharmaceuticals, Inc. (D.N.J., 1:13-cv-01580), lawyers from Foley & Lardner represented ... Angela C. Ni; Eric W. Dittmann; Jason T. Christiansen.